BCMO1 Beta Carotene
Summary
Your BCMO1 result determines how efficiently you convert plant-based beta-carotene into usable vitamin A — TT carriers convert up to 69% less than normal, making preformed vitamin A from animal sources (liver, eggs, dairy) essential rather than optional.
Genotype spectrum
You can reliably obtain vitamin A from plant sources. Carrots, sweet potato, spinach, and other carotenoid-rich foods genuinely work as vitamin A sources for you.
You still convert beta-carotene — just less efficiently. This means you retain more intact carotenoids in circulation, which actually increases your antioxidant carotenoid levels (this is genuinely beneficial for skin protection and cellular defence).
You retain the most carotenoids intact — your antioxidant carotenoid levels are naturally higher than most people. This is a genuine advantage for skin health, UV protection, and cellular antioxidant defence.
Practical takeaway
For TT Carriers (Significantly Reduced Conversion — Dietary Action Required)
Preformed vitamin A sources — make these regular:
• Liver (beef or chicken): The richest retinol source by far. A single 75g serving contains 5000-7000 mcg retinol — weeks of supply. Even once monthly covers your baseline needs. If you enjoy pate, that counts.
• Eggs: 2-3 eggs provides ~300 mcg retinol. 3-4 eggs per week contributes meaningfully.
• Dairy: Full-fat milk, cheese, and butter contain retinol. Skim/low-fat versions have significantly less.
• Oily fish: Salmon, mackerel, sardines provide retinol plus omega-3s.
• Cod liver oil: One teaspoon provides ~1350 mcg retinol + vitamin D. Efficient but watch for vitamin A excess if also eating liver regularly.
If vegan (TT genotype):
• This is one of the few genotypes that creates a genuine nutritional challenge for strict veganism. You cannot reliably obtain adequate vitamin A from plant sources.
• Discuss retinol or retinyl palmitate supplementation with your provider. Dose: 700-900 mcg retinol equivalents (RAE) daily.
• Fortified foods (plant milks, cereals) typically contain beta-carotene, not retinol — they don't solve your problem.
• Some vegan retinol supplements exist (derived from microbial fermentation). These are the appropriate solution.
Keep eating colourful vegetables:
• Your carotenoid intake still provides antioxidant benefits — possibly more than AA carriers, since you retain more intact carotenoids.
• Carrots, sweet potato, spinach, kale, mango, papaya — continue eating these for their non-vitamin-A benefits.
• Just don't count them toward your vitamin A requirement.
Monitoring:
• If concerned about vitamin A status, serum retinol testing is available (normal: 30-65 mcg/dL).
• Retinol levels are tightly regulated by the liver and only drop below normal in genuine deficiency — so low serum retinol is a late sign.
• Symptoms of subclinical deficiency: dry eyes, poor night vision adaptation, rough/dry skin, frequent infections.
What "working" looks like:
• No dry eye symptoms or night vision issues
• Healthy skin without unexplained dryness
• Normal immune function
• If previously symptomatic: resolution within 2-4
Evidence detail
What This Gene Does
BCMO1 encodes beta-carotene 15,15'-monooxygenase, the enzyme that cleaves beta-carotene in half at its central double bond to produce two molecules of retinal (vitamin A aldehyde). This is the primary pathway by which plant carotenoids become usable vitamin A. Without efficient BCMO1, the orange pigment in carrots, sweet potato, and spinach stays as carotenoid — antioxidant, but not vitamin A.
This matters because vitamin A is essential for vision, immune function, skin health, cell differentiation, and reproductive health. If you're relying on plant sources for your vitamin A and your BCMO1 is impaired, you may be functionally deficient even with a diet rich in colourful vegetables. This is one of the most directly actionable findings in nutrigenomics — the dietary adjustment is clear, simple, and immediately implementable.
Mechanism
Beta-carotene to vitamin A conversion works like this:
1. Dietary beta-carotene (from carrots, sweet potato, spinach, mango, etc.) is absorbed in the small intestine with dietary fat. Absorption requires bile salts and fat — beta-carotene in a fat-free meal is poorly absorbed regardless of genotype.
2. BCMO1 enzyme in intestinal enterocytes cleaves beta-carotene at the central 15,15' double bond, producing two molecules of retinal (retinaldehyde).
3. Retinal is then reduced to retinol (vitamin A alcohol), esterified to retinyl esters for storage, or oxidised to retinoic acid for gene regulation.
4. Retinol enters circulation bound to retinol-binding protein (RBP) and is distributed to target tissues.
What rs12934922 does:
The T allele of rs12934922 reduces BCMO1 enzyme activity. The precise molecular mechanism involves altered enzyme kinetics — reduced V_max (maximum reaction velocity) without changing K_m (substrate binding). The enzyme binds beta-carotene normally but processes it more slowly. One impaired copy (AT) reduces throughput by ~32%. Two impaired copies (TT) reduce it by ~69%.
Why this isn't a disaster:
Unconverted beta-carotene isn't wasted. It circulates as an intact carotenoid with genuine antioxidant properties — scavenging singlet oxygen and peroxyl radicals. TT carriers actually have higher circulating carotenoid levels, which is protective for skin, retinal health, and possibly cardiovascular function. The problem is specifically vitamin A supply, not carotenoid benefit.
Why preformed vitamin A bypasses the problem:
Retinol from animal sources (liver, eggs, dairy, fish) enters the body as ready-made vitamin A — it doesn't require BCMO1 conversion. It's absorbed directly and enters the retinol pool immediately. For TT carriers, this isn't a supplement — it's a food choice that routes around a genetic bottleneck.
The iron connection:
BCMO1 requires iron (Fe²⁺) as a cofactor. Iron deficiency — which is common, particularly in menstruating women and vegetarians — can further reduce BCMO1 activity even in AA carriers. For TT carriers who are also iron-deficient, the compound effect could be severe: impaired enzyme + missing cofactor.
Sources (6)
- Leung WC, et al. "Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15'-monoxygenase alter beta-carotene metabolism in female volunteers." FASEB Journal, 2009; 23(4):1041-1053. (Government-funded — USDA/ARS)↗
- Lietz G, et al. "Single nucleotide polymorphisms upstream from the beta-carotene 15,15'-monoxygenase gene influence provitamin A conversion efficiency in female volunteers." Journal of Nutrition, 2012; 142(1):161S-165S. (Government-funded — UK Biotechnology and Biological Sciences Research Council)↗
- Lin M, et al. "Cloning and functional characterization of the human beta-carotene 15,15'-dioxygenase." Journal of Biological Chemistry, 2000; 275(15):11915-11920. (Government-funded — NIH)↗
- Lindqvist A, Andersson S. "Biochemical properties of purified recombinant human beta-carotene 15,15'-monooxygenase." Journal of Biological Chemistry, 2002; 277(26):23942-23948. (Government-funded — Swedish Research Council)↗
- Borel P, et al. "Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in a healthy population." Human Molecular Genetics, 2011; 20(22):4556-4565. (Government-funded — INRA France)↗
- Hendrickson SJ, et al. "Beta-carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent." American Journal of Clinical Nutrition, 2012; 96(6):1379-1389. (Government-funded — NIH/NHLBI)↗